Department of Biotechnology and Bioinformatics, Korea University, Sejong-Ro 2511, Sejong 30019, Republic of Korea.
Department of Botany and Microbiology, Faculty of Science, Minia University, Minia 61519, Egypt.
Int J Mol Sci. 2024 Jun 1;25(11):6125. doi: 10.3390/ijms25116125.
The paradigm of regenerative medicine is undergoing a transformative shift with the emergence of nanoengineered silica-based biomaterials. Their unique confluence of biocompatibility, precisely tunable porosity, and the ability to modulate cellular behavior at the molecular level makes them highly desirable for diverse tissue repair and regeneration applications. Advancements in nanoengineered silica synthesis and functionalization techniques have yielded a new generation of versatile biomaterials with tailored functionalities for targeted drug delivery, biomimetic scaffolds, and integration with stem cell therapy. These functionalities hold the potential to optimize therapeutic efficacy, promote enhanced regeneration, and modulate stem cell behavior for improved regenerative outcomes. Furthermore, the unique properties of silica facilitate non-invasive diagnostics and treatment monitoring through advanced biomedical imaging techniques, enabling a more holistic approach to regenerative medicine. This review comprehensively examines the utilization of nanoengineered silica biomaterials for diverse applications in regenerative medicine. By critically appraising the fabrication and design strategies that govern engineered silica biomaterials, this review underscores their groundbreaking potential to bridge the gap between the vision of regenerative medicine and clinical reality.
再生医学的范式正在发生转变,纳米工程化的硅基生物材料应运而生。它们具有独特的生物相容性、可精确调节的孔隙率以及在分子水平上调节细胞行为的能力,使其成为各种组织修复和再生应用的理想选择。纳米工程化硅合成和功能化技术的进步,产生了新一代多功能生物材料,具有针对靶向药物输送、仿生支架以及与干细胞治疗相结合的定制功能。这些功能有可能优化治疗效果、促进增强的再生,并调节干细胞行为以获得更好的再生结果。此外,硅的独特性质通过先进的生物医学成像技术促进了非侵入性诊断和治疗监测,为再生医学提供了更全面的方法。本综述全面考察了纳米工程化硅生物材料在再生医学中的多种应用。通过批判性地评估控制工程化硅生物材料的制造和设计策略,本综述强调了它们在弥合再生医学的愿景与临床现实之间差距方面的开创性潜力。
Int J Mol Sci. 2024-6-1
Tissue Eng Part B Rev. 2020-4
Curr Med Chem. 2016
Acta Biomater. 2018-4-4
Methods Mol Biol. 2023
Int J Mol Sci. 2025-7-2
Polymers (Basel). 2025-1-20
Int J Mol Sci. 2024-4-25
Eur J Pharm Sci. 2024-4-1
Tissue Eng Part A. 2024-7
Int J Biol Macromol. 2024-1
Nanoscale Adv. 2023-8-25
J Mater Chem B. 2023-10-25
Clin Ther. 2023-11